
TY  - JOUR
TI  - Abstracts for Poster sessions
JO  - Cytometry
JA  - Cytometry
VL  - 8
IS  - S1
SN  - 0196-4763
UR  - https://doi.org/10.1002/cyto.990080704
DO  - doi:10.1002/cyto.990080704
SP  - 34
EP  - 104
PY  - 1987
ER  - 

TY  - JOUR
TI  - British Society for Investigative Dermatology Annual Meeting, Oxford University, September 1985
JO  - British Journal of Dermatology
VL  - 113
IS  - 6
SN  - 0007-0963
UR  - https://doi.org/10.1111/j.1365-2133.1985.tb02414.x
DO  - doi:10.1111/j.1365-2133.1985.tb02414.x
SP  - 761
EP  - 795
PY  - 1985
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 43
IS  - 9s
SN  - 0041-1132
UR  - https://doi.org/10.1046/j.1537-2995.43.9s.6.x
DO  - doi:10.1046/j.1537-2995.43.9s.6.x
SP  - 1A
EP  - 130A
PY  - 2003
ER  - 

TY  - JOUR
AU  - Monk, P N
AU  - Scola, A-M
AU  - Madala, P
AU  - Fairlie, D P
TI  - Function, structure and therapeutic potential of complement C5a receptors
JO  - British Journal of Pharmacology
VL  - 152
IS  - 4
SN  - 0007-1188
UR  - https://doi.org/10.1038/sj.bjp.0707332
DO  - doi:10.1038/sj.bjp.0707332
SP  - 429
EP  - 448
KW  - complement
KW  - C5a
KW  - G protein
KW  - receptor
KW  - inflammation
KW  - immunity
KW  - antagonist
PY  - 2007
AB  - Complement fragment (C)5a is a 74 residue pro-inflammatory polypeptide produced during activation of the complement cascade of serum proteins in response to foreign surfaces such as microorganisms and tissue damaged by physical or chemical injury. C5a binds to at least two seven-transmembrane domain receptors, C5aR (C5R1, CD88) and C5L2 (gpr77), expressed ubiquitously on a wide variety of cells but particularly on the surface of immune cells like macrophages, neutrophils and T cells. C5aR is a classical G protein-coupled receptor that signals through Gαi and Gα16, whereas C5L2 does not appear to couple to G proteins and has no known signalling activity. Although C5a was first described as an anaphylatoxin and later as a leukocyte chemoattractant, the widespread expression of C5aR suggested more general functionality. Our understanding of the physiology of C5a has improved significantly in recent years through exploitation of receptor knockout and knockin mice, C5 and C5a antibodies, soluble recombinant C5a and C5a analogues and newly developed receptor antagonists. C5a is now also implicated in non-immunological functions associated with developmental biology, CNS development and neurodegeneration, tissue regeneration, and haematopoiesis. Combined receptor mutagenesis, molecular modelling, structure-activity relationship studies and species dependence for ligand potency on C5aR have been helpful for identifying ligand binding sites on the receptor and for defining mechanisms of receptor activation and inactivation. This review will highlight major developments in C5a receptor research that support C5aR as an important therapeutic target. The intriguing possibilities raised by the existence of a non-signalling C5a receptor are also discussed. British Journal of Pharmacology (2007) 152, 429?448; doi:10.1038/sj.bjp.0707332; published online 2 July 2007
ER  - 

TY  - JOUR
AU  - Slutsky, Arthur S.
AU  - Silliman, Christopher C.
AU  - Brand, Anneke
AU  - Wallis, Jonathan P.
TI  - ARDS-TRALI
JO  - Transfusion Alternatives in Transfusion Medicine
VL  - 6
IS  - s1
SN  - 1295-9022
UR  - https://doi.org/10.1111/j.1778-428X.2004.tb00143.x
DO  - doi:10.1111/j.1778-428X.2004.tb00143.x
SP  - 45
EP  - 50
PY  - 2004
ER  - 

TY  - JOUR
TI  - Abstracts From the American Society for Apheresis 27th Annual Meeting, May 23-26, 2006 Las Vegas, Nevada
JO  - Journal of Clinical Apheresis
JA  - J. Clin. Apheresis
VL  - 21
IS  - 1
SN  - 0733-2459
UR  - https://doi.org/10.1002/jca.20098
DO  - doi:10.1002/jca.20098
SP  - 1
EP  - 48
PY  - 2006
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Reproduction in Domestic Animals
JA  - Reprod Dom Anim
VL  - 52
IS  - S3
SN  - 0936-6768
UR  - https://doi.org/10.1111/rda.13026
DO  - doi:10.1111/rda.13026
SP  - 66
EP  - 146
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Mycoses
VL  - 52
IS  - s1
SN  - 0933-7407
UR  - https://doi.org/10.1111/j.1439-0507.2009.01782.x
DO  - doi:10.1111/j.1439-0507.2009.01782.x
SP  - 29
EP  - 123
PY  - 2009
ER  - 

TY  - JOUR
TI  - 43rd Annual Meeting of the German-Speaking Mycological Society (DMykG)
JO  - Mycoses
VL  - 52
IS  - 5
SN  - 0933-7407
UR  - https://doi.org/10.1111/j.1439-0507.2009.01764.x
DO  - doi:10.1111/j.1439-0507.2009.01764.x
SP  - 383
EP  - 432
PY  - 2009
ER  - 

C7  - pp. 454-461
TI  - Index
SN  - 9780470654613
UR  - https://doi.org/10.1002/9781118274231.index
DO  - doi:10.1002/9781118274231.index
SP  - 454-461
PY  - 2009
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 24th Annual ACVIM Forum Louisville, KY, May 31 - June 3, 2006
JO  - Journal of Veterinary Internal Medicine
VL  - 20
IS  - 3
SN  - 9780470654613
UR  - https://doi.org/10.1111/j.1939-1676.2006.tb02919.x
DO  - doi:10.1111/j.1939-1676.2006.tb02919.x
SP  - 697
EP  - 802
PY  - 2006
ER  - 

TY  - JOUR
TI  - Subspeciality: Cardiovacular medicine
JO  - European Journal of Clinical Investigation
VL  - 31
IS  - s1
SN  - 9780470654613
UR  - https://doi.org/10.1111/j.1365-2362.2001.00001.x
DO  - doi:10.1111/j.1365-2362.2001.00001.x
SP  - 1
EP  - 44
PY  - 2001
ER  - 

TY  - JOUR
TI  - MICROBIOLOGY OF THE LOWER RESPIRATORY TRACT IN INFANTS WITH CYSTIC FIBROSIS
JO  - Australian and New Zealand Journal of Medicine
VL  - 23
IS  - 4
SN  - 9780470654613
UR  - https://doi.org/10.1111/j.1445-5994.1993.tb01459.x
DO  - doi:10.1111/j.1445-5994.1993.tb01459.x
SP  - 438
EP  - 446
PY  - 1993
ER  - 

TY  - JOUR
TI  - ABSTRACTS OF SCIENTIFIC PAPERS PRESENTED AT THE INTERNATIONAL PAEDIATRIC CONFERENCE, SYDNEY, MAY 14–18,1978.
JO  - Journal of Paediatrics and Child Health
VL  - 15
IS  - s1
SN  - 9780470654613
UR  - https://doi.org/10.1111/j.1440-1754.1979.tb01263.x
DO  - doi:10.1111/j.1440-1754.1979.tb01263.x
SP  - 44
EP  - 65
PY  - 1979
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 50
IS  - S41
SN  - 9780470654613
UR  - https://doi.org/10.1002/ppul.23297
DO  - doi:10.1002/ppul.23297
SP  - S193
EP  - S453
PY  - 2015
ER  - 

TY  - JOUR
TI  - American Society of Pediatric Hematology/Oncology 18th Annual Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 44
IS  - 6
SN  - 9780470654613
UR  - https://doi.org/10.1002/pbc.20423
DO  - doi:10.1002/pbc.20423
SP  - 529
EP  - 577
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster session abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 16
IS  - S9
SN  - 9780470654613
UR  - https://doi.org/10.1002/ppul.1950160706
DO  - doi:10.1002/ppul.1950160706
SP  - 203
EP  - 298
PY  - 1993
ER  - 

TY  - JOUR
AU  - Cantu, David Antonio
AU  - Kao, W. John
TI  - Combinatorial Biomatrix/Cell-Based Therapies for Restoration of Host Tissue Architecture and Function
JO  - Advanced Healthcare Materials
JA  - Advanced Healthcare Materials
VL  - 2
IS  - 12
SN  - 9780470654613
UR  - https://doi.org/10.1002/adhm.201300063
DO  - doi:10.1002/adhm.201300063
SP  - 1544
EP  - 1563
KW  - biomaterials
KW  - cell-based therapy
KW  - cell presentation
KW  - extracellular matrix
KW  - foreign body response
PY  - 2013
AB  - Abstract This Progress Report reviews recent advances in the utility of extracellular matrix (ECM)-mimic biomaterials in presenting and delivering therapeutic cells to promote tissue healing. This overview gives a brief introduction of different cell types being used in regenerative medicine and tissue engineering while addressing critical issues that must be overcome before cell-based approaches can be routinely employed in the clinic. A selection of five commonly used cell-associated, biomaterial platforms (collagen, hyaluronic acid, fibrin, alginate, and poly(ethylene glycol)) are reviewed for treatment of a number of acute injury or diseases with emphasis on animal models and clinical trials. This article concludes with current challenges and future perspectives regarding foreign body host response to biomaterials and immunological reactions to allogeneic or xenogeneic cells, vascularization and angiogenesis, matching mechanical strength and anisotropy of native tissues, as well as other non-technical issues regarding the clinical translation of biomatrix/cell-based therapies.
ER  - 

TY  - JOUR
TI  - ACR/ARHP scientific abstracts
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 42
IS  - S9
SN  - 9780470654613
UR  - https://doi.org/10.1002/art.1780422107
DO  - doi:10.1002/art.1780422107
SP  - S71
EP  - S407
PY  - 1999
ER  - 

TY  - JOUR
TI  - Abstracts accepted for publication only
JO  - Clinical Microbiology and Infection
VL  - 18
IS  - s3
SN  - 9780470654613
UR  - https://doi.org/10.1111/j.1469-0691.2012.03803.x
DO  - doi:10.1111/j.1469-0691.2012.03803.x
SP  - 716
EP  - 844
PY  - 2012
ER  - 
